Kapitalo Investimentos Ltda Invests $178,000 in Stryker Co. (NYSE:SYK)

Kapitalo Investimentos Ltda bought a new position in Stryker Co. (NYSE:SYK) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 596 shares of the medical technology company’s stock, valued at approximately $178,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Carnegie Capital Asset Management LLC grew its position in shares of Stryker by 0.5% during the 4th quarter. Carnegie Capital Asset Management LLC now owns 96,241 shares of the medical technology company’s stock valued at $28,820,000 after buying an additional 497 shares during the last quarter. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of Stryker during the 4th quarter valued at about $1,561,000. CoreCap Advisors LLC grew its position in shares of Stryker by 3.9% during the 4th quarter. CoreCap Advisors LLC now owns 5,030 shares of the medical technology company’s stock valued at $1,506,000 after buying an additional 191 shares during the last quarter. Consolidated Planning Corp bought a new stake in shares of Stryker during the 4th quarter valued at about $205,000. Finally, Meritage Portfolio Management bought a new stake in shares of Stryker during the 4th quarter valued at about $569,000. Institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

SYK has been the subject of several recent analyst reports. Roth Mkm upped their target price on shares of Stryker from $348.00 to $405.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. UBS Group upped their price target on shares of Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 1st. Needham & Company LLC raised shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price target for the company in a research note on Wednesday, May 22nd. Barclays increased their target price on shares of Stryker from $372.00 to $376.00 and gave the company an “overweight” rating in a research note on Thursday, May 2nd. Finally, TD Cowen increased their target price on shares of Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $370.58.

Stryker Stock Up 1.2 %

Shares of NYSE:SYK opened at $348.67 on Wednesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.99 and a current ratio of 1.71. The company has a market cap of $132.83 billion, a PE ratio of 39.80, a price-to-earnings-growth ratio of 2.71 and a beta of 0.92. Stryker Co. has a 52 week low of $249.98 and a 52 week high of $361.41. The firm has a 50 day simple moving average of $336.74 and a 200 day simple moving average of $331.10.

Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.36 by $0.14. The firm had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company’s revenue for the quarter was up 9.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.14 EPS. As a group, research analysts expect that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be paid a $0.80 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 annualized dividend and a yield of 0.92%. Stryker’s dividend payout ratio is presently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.